Elevated fat levels in your liver can raise your chances of developing serious health issues, including diabetes, ...
The trials identified no serious adverse effects, and patients tolerated a daily dosage of 1500 mg for 24 weeks.
Non-alcoholic fatty liver disease (NAFLD) affects nearly 19 crore people in India and about a quarter of the world’s ...
GlobalData on MSN4d
Eli Lilly pledges $630m on OliX’s Phase I RNA candidate for MASHLilly will provide an initial payment to complete a Phase I trial of OLX75016, which started in February 2024.
The spike in Shilpa Medicare's stock price came after the company announced the approval of its Investigational New Drug (IND ...
Hosted on MSN2d
Scotiabank Initiates Coverage of Viking Therapeutics (VKTX) with Sector Outperform RecommendationFintel reports that on February 13, 2025, Scotiabank initiated coverage of Viking Therapeutics (NasdaqCM:VKTX) with a Sector ...
News Medical on MSN4d
Adrenomedullin hormone as key driver of insulin resistance in obesity-linked type 2 diabetesResearchers investigate the underlying mechanisms of endothelial insulin resistance involved in obesity-associated diabetes.
Stock analysts at StockNews.com assumed coverage on shares of DURECT (NASDAQ:DRRX – Get Free Report) in a research report issued on Saturday. The brokerage set a “sell” rating on the specialty ...
Oxford Mail on MSN1d
Building contractor, 44, collapses and dies at city homeAn inquest has opened into the death of a building contractor who collapsed at a property in Islip Road in Oxford.
Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback